Presentation is loading. Please wait.

Presentation is loading. Please wait.

From: GCAP1, Rab6, and HSP27: Novel Autoantibody Targets in Cancer-Associated Retinopathy and Autoimmune Retinopathy Trans. Vis. Sci. Tech.. 2016;5(3):1.

Similar presentations


Presentation on theme: "From: GCAP1, Rab6, and HSP27: Novel Autoantibody Targets in Cancer-Associated Retinopathy and Autoimmune Retinopathy Trans. Vis. Sci. Tech.. 2016;5(3):1."— Presentation transcript:

1 From: GCAP1, Rab6, and HSP27: Novel Autoantibody Targets in Cancer-Associated Retinopathy and Autoimmune Retinopathy Trans. Vis. Sci. Tech ;5(3):1. doi: /tvst.5.3.1 Figure Legend: Statistical analysis of seropositive patients with and without cancer having anti-recoverin and other anti-23-kDa AAbs. (A) Four groups of seropositive patients with and without cancer were analyzed by χ2 analysis (***P = , χ2 test) and t Fisher's exact test (significance denoted by asterisks). (B) Patients with anti-recoverin antibodies had higher likelihood of having cancer than with other anti-23-kDa AAbs (***P = , Fisher's exact test). CA(+), patients with cancer; CA(−), patients without cancer. Date of download: 11/12/2017 The Association for Research in Vision and Ophthalmology Copyright © All rights reserved.


Download ppt "From: GCAP1, Rab6, and HSP27: Novel Autoantibody Targets in Cancer-Associated Retinopathy and Autoimmune Retinopathy Trans. Vis. Sci. Tech.. 2016;5(3):1."

Similar presentations


Ads by Google